Shenlingcao Oral Liquid for Patients With Stage II or IIIA NSCLC
NCT03712969
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
527
Enrollment
OTHER
Sponsor class
Conditions
Carcinoma, Non-Small-Cell Lung
Chemotherapy, Adjuvant
Interventions
DRUG:
Shenlingcao Oral Liquid
Sponsor
West China Hospital